• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 WW 结构域激活的细胞外囊泡展示和递呈病毒膜抗原。

Displaying and delivering viral membrane antigens via WW domain-activated extracellular vesicles.

机构信息

Program in Molecular and Integrative Physiological Sciences, Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.

Nebraska Center for Virology, School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE 68583, USA.

出版信息

Sci Adv. 2023 Jan 27;9(4):eade2708. doi: 10.1126/sciadv.ade2708.

DOI:10.1126/sciadv.ade2708
PMID:36706192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9882979/
Abstract

Membrane proteins expressed on the surface of enveloped viruses are conformational antigens readily recognized by B cells of the immune system. An effective vaccine would require the synthesis and delivery of these native conformational antigens in lipid membranes that preserve specific epitope structures. We have created an extracellular vesicle-based technology that allows viral membrane antigens to be selectively recruited onto the surface of WW domain-activated extracellular vesicles (WAEVs). Budding of WAEVs requires secretory carrier-associated membrane protein 3, which through its proline-proline-alanine-tyrosine motif interacts with WW domains to recruit fused viral membrane antigens onto WAEVs. Immunization with influenza and HIV viral membrane proteins displayed on WAEVs elicits production of virus-specific neutralizing antibodies and, in the case of influenza antigens, protects mice from the lethal viral infection. WAEVs thus represent a versatile platform for presenting and delivering membrane antigens as vaccines against influenza, HIV, and potentially many other viral pathogens.

摘要

包膜病毒表面表达的膜蛋白是构象抗原,可被免疫系统的 B 细胞轻易识别。有效的疫苗需要在脂质膜中合成和递呈这些天然构象抗原,以保留特定表位结构。我们创建了一种基于细胞外囊泡的技术,可将病毒膜抗原选择性募集到 WW 结构域激活的细胞外囊泡(WAEV)表面。WAEV 的出芽需要分泌载体相关膜蛋白 3,其通过脯氨酸-脯氨酸-丙氨酸-酪氨酸基序与 WW 结构域相互作用,将融合的病毒膜抗原募集到 WAEV 上。用展示在 WAEV 上的流感和 HIV 病毒膜蛋白免疫小鼠可诱导产生针对病毒的中和抗体,并且在流感抗原的情况下,可保护小鼠免受致命的病毒感染。因此,WAEV 是一种多功能平台,可作为针对流感、HIV 以及潜在许多其他病毒病原体的疫苗来展示和递呈膜抗原。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d9d/9882979/e3d0fdc6f7af/sciadv.ade2708-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d9d/9882979/e5fc1e4164f9/sciadv.ade2708-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d9d/9882979/27079be663c0/sciadv.ade2708-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d9d/9882979/3a6b4b0e192d/sciadv.ade2708-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d9d/9882979/80be976704cd/sciadv.ade2708-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d9d/9882979/e3d0fdc6f7af/sciadv.ade2708-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d9d/9882979/e5fc1e4164f9/sciadv.ade2708-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d9d/9882979/27079be663c0/sciadv.ade2708-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d9d/9882979/3a6b4b0e192d/sciadv.ade2708-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d9d/9882979/80be976704cd/sciadv.ade2708-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d9d/9882979/e3d0fdc6f7af/sciadv.ade2708-f5.jpg

相似文献

1
Displaying and delivering viral membrane antigens via WW domain-activated extracellular vesicles.通过 WW 结构域激活的细胞外囊泡展示和递呈病毒膜抗原。
Sci Adv. 2023 Jan 27;9(4):eade2708. doi: 10.1126/sciadv.ade2708.
2
Characterization of influenza H1N1 Gag virus-like particles and extracellular vesicles co-produced in HEK-293SF.鉴定 HEK-293SF 中共表达的甲型流感 H1N1 衣壳病毒样颗粒和细胞外囊泡
Vaccine. 2019 Nov 8;37(47):7100-7107. doi: 10.1016/j.vaccine.2019.07.057. Epub 2019 Jul 26.
3
Bio-inspired virus-like nanovesicle for effective vaccination.用于有效疫苗接种的仿生病毒样纳米囊泡。
Hum Vaccin Immunother. 2016 Aug 2;12(8):2090-2091. doi: 10.1080/21645515.2016.1157244. Epub 2016 May 4.
4
Safe Recombinant Outer Membrane Vesicles that Display M2e Elicit Heterologous Influenza Protection.展示M2e的安全重组外膜囊泡可引发异源流感保护。
Mol Ther. 2017 Apr 5;25(4):989-1002. doi: 10.1016/j.ymthe.2017.01.010. Epub 2017 Feb 16.
5
Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB/c mice.重组M2e外膜囊泡疫苗可保护BALB/c小鼠免受致死性甲型流感病毒攻击。
Vaccine. 2016 Mar 4;34(10):1252-8. doi: 10.1016/j.vaccine.2016.01.028. Epub 2016 Jan 29.
6
Antigenicity and immunogenicity of HA2 and M2e influenza virus antigens conjugated to norovirus-like, VP1 capsid-based particles by the SpyTag/SpyCatcher technology.通过 SpyTag/SpyCatcher 技术将流感病毒 HA2 和 M2e 抗原与诺如病毒样、基于 VP1 衣壳的颗粒偶联后的抗原性和免疫原性。
Virology. 2022 Jan;566:89-97. doi: 10.1016/j.virol.2021.12.001. Epub 2021 Dec 3.
7
Generalized Modules for Membrane Antigens (GMMA), an outer membrane vesicle-based vaccine platform, for efficient viral antigen delivery.通用膜抗原模块(GMMA),一种基于外膜囊泡的疫苗平台,用于有效递呈病毒抗原。
J Extracell Vesicles. 2022 Nov;11(11):e12247. doi: 10.1002/jev2.12247.
8
A virus-like particle vaccine candidate for influenza A virus based on multiple conserved antigens presented on hepatitis B tandem core particles.基于乙型肝炎串联核心颗粒上呈现的多种保守抗原的甲型流感病毒样颗粒疫苗候选物。
Vaccine. 2018 Feb 1;36(6):873-880. doi: 10.1016/j.vaccine.2017.12.053. Epub 2018 Jan 3.
9
Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.展示流感病毒蛋白并诱导保护性免疫的禽病毒衣壳发育的结构基础。
J Virol. 2015 Mar;89(5):2563-74. doi: 10.1128/JVI.03025-14. Epub 2014 Dec 17.
10
A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages.一种经过计算优化的具有广泛反应性的血凝素疫苗,可诱导针对两种谱系的乙型流感病毒的中和抗体。
Sci Rep. 2023 Sep 23;13(1):15911. doi: 10.1038/s41598-023-43003-2.

引用本文的文献

1
A Novel Trivalent BVDV mRNA Vaccine Displayed by Virus-like Particles Eliciting Potent and Broad-Spectrum Antibody Responses.一种由病毒样颗粒展示的新型三价牛病毒性腹泻病毒mRNA疫苗,可引发强效和广谱抗体反应。
Vaccines (Basel). 2025 Jun 26;13(7):691. doi: 10.3390/vaccines13070691.
2
Advancements in the conservation of the conformational epitope of membrane protein immunogens.膜蛋白免疫原构象表位保守性研究进展。
Front Immunol. 2025 Feb 28;16:1538871. doi: 10.3389/fimmu.2025.1538871. eCollection 2025.
3
Inverted HA-EV immunization elicits stalk-specific influenza immunity and cross-protection in mice.

本文引用的文献

1
Protein engineering strategies for rational immunogen design.用于合理免疫原设计的蛋白质工程策略。
NPJ Vaccines. 2021 Dec 17;6(1):154. doi: 10.1038/s41541-021-00417-1.
2
mRNA Vaccines in the COVID-19 Pandemic and Beyond.mRNA 疫苗在 COVID-19 大流行及以后的应用
Annu Rev Med. 2022 Jan 27;73:17-39. doi: 10.1146/annurev-med-042420-112725. Epub 2021 Oct 20.
3
mRNA vaccines for infectious diseases: principles, delivery and clinical translation.传染病的 mRNA 疫苗:原理、传递和临床转化。
倒置的血凝素-外泌体免疫在小鼠中引发茎特异性流感免疫和交叉保护。
Mol Ther. 2025 Feb 5;33(2):485-498. doi: 10.1016/j.ymthe.2024.12.052. Epub 2024 Dec 30.
4
Optical Imaging of Single Extracellular Vesicles: Recent Progress and Prospects.单个细胞外囊泡的光学成像:最新进展与展望。
Chem Biomed Imaging. 2023 Dec 15;2(1):27-46. doi: 10.1021/cbmi.3c00095. eCollection 2024 Jan 22.
5
Significance of VLPs in Vlp-circRNA vaccines: a vaccine candidate or delivery vehicle?VLPs 在 Vlp-circRNA 疫苗中的意义:疫苗候选物还是递送载体?
RNA Biol. 2024 Jan;21(1):17-28. doi: 10.1080/15476286.2024.2399307. Epub 2024 Sep 6.
6
Extracellular vesicle surface display of αPD-L1 and αCD3 antibodies via engineered late domain-based scaffold to activate T-cell anti-tumor immunity.通过基于工程晚期结构域的支架在细胞外囊泡表面展示 αPD-L1 和 αCD3 抗体,激活 T 细胞抗肿瘤免疫。
J Extracell Vesicles. 2024 Jul;13(7):e12490. doi: 10.1002/jev2.12490.
7
Trick-or-Trap: Extracellular Vesicles and Viral Transmission.诱骗还是陷阱:细胞外囊泡与病毒传播
Vaccines (Basel). 2023 Sep 27;11(10):1532. doi: 10.3390/vaccines11101532.
Nat Rev Drug Discov. 2021 Nov;20(11):817-838. doi: 10.1038/s41573-021-00283-5. Epub 2021 Aug 25.
4
Vaccine development for emerging infectious diseases.新发传染病疫苗的研发。
Nat Med. 2021 Apr;27(4):591-600. doi: 10.1038/s41591-021-01301-0. Epub 2021 Apr 12.
5
Emerging concepts in the science of vaccine adjuvants.疫苗佐剂科学中的新观点。
Nat Rev Drug Discov. 2021 Jun;20(6):454-475. doi: 10.1038/s41573-021-00163-y. Epub 2021 Apr 6.
6
New SHIVs and Improved Design Strategy for Modeling HIV-1 Transmission, Immunopathogenesis, Prevention and Cure.用于模拟HIV-1传播、免疫发病机制、预防和治疗的新型SHIVs及改进设计策略。
J Virol. 2021 May 10;95(11). doi: 10.1128/JVI.00071-21. Epub 2021 Mar 3.
7
A guide to vaccinology: from basic principles to new developments.疫苗学指南:从基本原则到新进展。
Nat Rev Immunol. 2021 Feb;21(2):83-100. doi: 10.1038/s41577-020-00479-7. Epub 2020 Dec 22.
8
Viral targets for vaccines against COVID-19.针对 COVID-19 的疫苗的病毒靶点。
Nat Rev Immunol. 2021 Feb;21(2):73-82. doi: 10.1038/s41577-020-00480-0. Epub 2020 Dec 18.
9
A Decade in Review: A Systematic Review of Universal Influenza Vaccines in Clinical Trials during the 2010 Decade.十年回顾:2010 年代临床试验中通用流感疫苗的系统评价。
Viruses. 2020 Oct 20;12(10):1186. doi: 10.3390/v12101186.
10
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate.全长 SARS-CoV-2 刺突蛋白的结构分析来自一种先进的疫苗候选物。
Science. 2020 Nov 27;370(6520):1089-1094. doi: 10.1126/science.abe1502. Epub 2020 Oct 20.